Back to search
BARD1 Gene Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which BARD1 Gene Mutation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which BARD1 Gene Mutation trials you may qualify forThe purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.
The purpose of this study is to examine the impact of new cancer genetic counseling models that aim to increase patient engagement with the genetics team. To do…
This randomized clinical trial studies how well online genetics educational video with or without pre- and/or post-telephone genetics counseling works in assess…
This phase II trial studies how well surgery works in preventing ovarian cancer in patients with genetic mutations at risk of ovarian cancer. Risk reducing salp…
This study will examine the combination of pembrolizumab and olaparib in three populations. * Cohort 1: aBC patients with a germline mutation in BRCA1 or BRCA2…